The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN)
Open accessAbstract
Myopia is a highly frequent ocular disorder worldwide and pathologic myopia is the 4th most common cause of irreversible blindness in developed countries. Pathologic myopia is especially common in East Asian countries. Ocular alterations associated with pathologic myopia, especially those involving the macular area-defined as myopic maculopathy-are the leading causes of vision loss in patients with pathologic myopia. High myopia is defined as the presence of a highly negative refractive error (>-6 to -8 diopters) in the context of eye elongation (26-26.5 mm). Although the terms high myopia and pathologic myopia are often used interchangeably, they do not refer to the same eye disease. The two key factors driving the development of pathologic myopia are: 1) elongation of the axial length and 2) posterior staphyloma. The presence of posterior staphyloma, which is the most common finding in patients with pathologic myopia, is the key differentiating factor between high and pathologic myopia. The occurrence of staphyloma will, in most cases, eventually lead to other conditions such as atrophic, traction, or neovascular maculopathy. Posterior staphyloma is for instance, responsible for the differences between a myopic macular hole (MH)-with and without retinal detachment-and idiopathic MH. Posterior staphyloma typically induces retinal layer splitting, leading to foveoschisis in myopic MH, an important differentiating factor between myopic and emmetropic MH. Myopic maculopathy is a highly complex disease and current classification systems do not fully account for the numerous changes that occur in the macula of these patients. Therefore, a more comprehensive classification system is needed, for several important reasons. First, to more precisely define the disease stage to improve follow-up by enabling clinicians to more accurately monitor changes over time, which is essential given the progressive nature of this condition. Second, unification of the currently-available classification systems would establish standardized classification criteria that could be used to compare the findings from international multicentric studies. Finally, a more comprehensive classification system could help to improve our understanding of the genetic origins of this disease, which is clearly relevant given the interchangeable-but erroneous-use of the terms high and pathologic myopia in genetic research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
Holden, B. A., Fricke, T. R., Wilson, D. A., Jong, M., Naidoo, K. S., Sankaridurg, P., Wong, T. Y., Naduvilath, T. J., & Resnikoff, S. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.006 · Cited by 5,500
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Morgan, I. G., Ohno-Matsui, K., & Saw, S.-M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60272-4 · Cited by 1,871
Kashani, A. H., Chen, C.-L., Gahm, J. K., Zheng, F., Richter, G. M., Rosenfeld, P. J., Shi, Y., & Wang, R. K. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.07.002 · Cited by 1,006
Klaver, C. C. W. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.5.653 · Cited by 881
International Photographic Classification and Grading System for Myopic Maculopathy
Ohno-Matsui, K., Kawasaki, R., Jonas, J. B., Cheung, C. M. G., Saw, S.-M., Verhoeven, V. J. M., Klaver, C. C. W., Moriyama, M., Shinohara, K., Kawasaki, Y., et al. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.01.022 · Cited by 866
Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Highly Myopic Eyes
Fujiwara, T., Imamura, Y., Margolis, R., Slakter, J. S., & Spaide, R. F. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.04.029 · Cited by 823
Wong, T. Y., Ferreira, A., Hughes, R., Carter, G., & Mitchell, P. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.08.010 · Cited by 758
Role of the sclera in the development and pathological complications of myopia
McBrien, N. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00063-0 · Cited by 616
Ohno-Matsui, K., Lai, T. Y. Y., Lai, C.-C., & Cheung, C. M. G. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.12.001 · Cited by 551
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin
(2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00544-9 · Cited by 546
Prevalence and Causes of Low Vision and Blindness in a Japanese Adult Population
Iwase, A., Araie, M., Tomidokoro, A., Yamamoto, T., Shimizu, H., & Kitazawa, Y. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.04.022 · Cited by 544
Long-term Pattern of Progression of Myopic Maculopathy
Hayashi, K., Ohno-Matsui, K., Shimada, N., Moriyama, M., Kojima, A., Hayashi, W., Yasuzumi, K., Nagaoka, N., Saka, N., Yoshida, T., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.11.003 · Cited by 510
PATHOLOGIC FINDINGS IN PATHOLOGIC MYOPIA
GROSSNIKLAUS, H. E., & GREEN, W. R. (1992) · Retina · doi:10.1097/00006982-199212020-00009 · Cited by 496
Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects.
Delori, F. C., Goger, D. G., & Dorey, C. K. (2001) · PubMed · Cited by 487
Prevalence and progression of myopic retinopathy in an older population
Vongphanit, J., Mitchell, P., & Wang, J. J. (2002) · Ophthalmology · doi:10.1016/s0161-6420(01)01024-7 · Cited by 458
VEGF is major stimulator in model of choroidal neovascularization.
Kwak, N., Okamoto, N., Wood, J. M., & Campochiaro, P. A. (2000) · PubMed · Cited by 442
The posterior staphyloma of pathologic myopia.
Curtin, B. J. (1977) · Europe PMC (PubMed Central) · Cited by 428
Myopic Choroidal Neovascularization
Cheung, C. M. G., Arnold, J. J., Holz, F. G., Park, K. H., Lai, T. Y. Y., Larsen, M., Mitchell, P., Ohno-Matsui, K., Chen, S.-J., Wolf, S., et al. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.04.028 · Cited by 416
Natural History of Choroidal Neovascularization in Degenerative Myopia
Avila, M. P., Weiter, J. J., Jalkh, A. E., Trempe, C. L., Pruett, R. C., & Schepens, C. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34116-1 · Cited by 402
Etiology of Choroidal Neovascularization in Young Patients
Cohen, S. Y., Laroche, A., Leguen, Y., Soubrane, G., & Coscas, G. J. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30515-0 · Cited by 392
Freund, K. B., Zweifel, S. A., & Engelbert, M. (2010) · Retina · doi:10.1097/iae.0b013e3181e7976b · Cited by 386
Tong, J.-P., Chan, W.-M., Liu, D. T. L., Lai, T. Y. Y., Choy, K.-W., Pang, C.-P., & Lam, D. S. C. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.10.012 · Cited by 385
Foster, P. J., & Jiang, Y. (2014) · Eye · doi:10.1038/eye.2013.280 · Cited by 379
Usui, S., Ikuno, Y., Akiba, M., Maruko, I., Sekiryu, T., Nishida, K., & Iida, T. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8383 · Cited by 370
Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults
Buch, H., Vinding, T., la Cour, M., Appleyard, M., Jensen, G. B., & Vesti Nielsen, N. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.05.010 · Cited by 367
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia
(2003) · Ophthalmology · doi:10.1016/s0161-6420(02)01998-x · Cited by 354
Prevalence and Progression of Myopic Retinopathy in Chinese Adults: The Beijing Eye Study
Liu, H. H., Xu, L., Wang, Y. X., Wang, S., You, Q. S., & Jonas, J. B. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.01.020 · Cited by 351
Wolf, S., Balciuniene, V. J., Laganovska, G., Menchini, U., Ohno-Matsui, K., Sharma, T., Wong, T. Y., Silva, R., Pilz, S., & Gekkieva, M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.10.023 · Cited by 317
Ohno‐Matsui, K. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.5.570 · Cited by 301
The Scleral Buckling Procedures: 1. Surgical Techniques and Management
SCHEPENS, C. L. (1957) · A.M.A. Archives of Ophthalmology · doi:10.1001/archopht.1957.00940010819003 · Cited by 285
Choroidal neovascularization in pathological myopia
Neelam, K., Cheung, C. M. G., Ohno-Matsui, K., Lai, T. Y. Y., & Wong, T. Y. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.04.001 · Cited by 265
Regional Variations in the Relationship between Macular Thickness Measurements and Myopia
Lam, D. S. C., Leung, K. S., Mohamed, S., Chan, W.-M., Palanivelu, M. S., Cheung, C. Y. L., Li, E. Y. M., Lai, R. Y. K., & Leung, C. K.-S. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0426 · Cited by 258
The process for continuous improvement of the TNM classification
Gospodarowicz, M. K., Miller, D., Groome, P. A., Greene, F. L., Logan, P. A., & Sobin, L. H. (2004) · Cancer · doi:10.1002/cncr.11898 · Cited by 250
Normal and Staphylomatous Sclera of High Myopia: An Electron Microscopic Study
Curtin, B. J. (1979) · Archives of Ophthalmology · doi:10.1001/archopht.1979.01020010470017 · Cited by 228
Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization
Ikuno, Y., Ohno-Matsui, K., Wong, T. Y., Korobelnik, J.-F., Vitti, R., Li, T., Stemper, B., Asmus, F., Zeitz, O., & Ishibashi, T. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.01.025 · Cited by 210
Prevalence and Risk Factors for Myopic Retinopathy in a Japanese Population
Asakuma, T., Yasuda, M., Ninomiya, T., Noda, Y., Arakawa, S., Hashimoto, S., Ohno-Matsui, K., Kiyohara, Y., & Ishibashi, T. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.02.034 · Cited by 186
Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia
Ohno-Matsui, K., Ikuno, Y., Lai, T. Y. Y., & Gemmy Cheung, C. M. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.005 · Cited by 185
Yamada, M., Hiratsuka, Y., Roberts, C. B., Pezzullo, M. L., Yates, K., Takano, S., Miyake, K., & Taylor, H. R. (2010) · Ophthalmic Epidemiology · doi:10.3109/09286580903450346 · Cited by 179
Vitreous cortex remnants at the fovea after spontaneous vitreous detachment
Kishi, S., Demaria, C., & Shimizu, K. (1986) · International Ophthalmology · doi:10.1007/bf00137539 · Cited by 177
Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes.
Vinores, S. A., Campochiaro, P. A., & Conway, B. P. (1990) · PubMed · Cited by 162
Causes of Low Vision and Blindness in Adult LatinosThe Los Angeles Latino Eye Study
Cotter, S. A., Varma, R., Ying-Lai, M., Azen, S., & Klein, R. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.002 · Cited by 158
Myopic choroidal neovascularisation: current concepts and update on clinical management
Wong, T. Y., Ohno‐Matsui, K., Leveziel, N., Holz, F. G., Lai, T. Y. Y., Yu, H. G., Lanzetta, P., Chen, Y., & Tufail, A. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305131 · Cited by 156
Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia
Nguyen, Q. D. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.066431 · Cited by 152
Prevalence of Posterior Vitreous Detachment in High Myopia
Akiba, J. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31471-5 · Cited by 144
Regulation of scleral metabolism in myopia and the role of transforming growth factor-beta
McBrien, N. A. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.01.014 · Cited by 144
Klein, R., Deng, Y., Klein, B. E. K., Hyman, L., Seddon, J., Frank, R. N., Wallace, R. B., Hendrix, S. L., Kuppermann, B. D., Langer, R. D., et al. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.058 · Cited by 142 · cited 10×
“Bevacizumab Several studies have reported excellent results with intravitreal anti-VEGF agents for the treatment of CNV secondary to AMD (Brown et al., 2006; Rosenfeld et al., 2006).”
InfluentialFactors associated with foveoschisis and foveal detachment without macular hole in high myopia
Wu, P.-C., Chen, Y.-J., Chen, Y.-H., Chen, C.-H., Shin, S., Tsai, C.-L., & Kuo, H.-K. (2007) · Eye · doi:10.1038/sj.eye.6703038 · Cited by 142
Yamanari, M., Makita, S., & Yasuno, Y. (2008) · Optics Express · doi:10.1364/oe.16.005892 · Cited by 138
Peripapillary chorioretinal atrophy
Curcio, C. A., Saunders, P. L., Younger, P. W., & Malek, G. (2000) · Ophthalmology · doi:10.1016/s0161-6420(99)00037-8 · Cited by 138
da Silva, R. M. (2012) · Ophthalmologica · doi:10.1159/000339893 · Cited by 129
Gharbiya, M., Allievi, F., Mazzeo, L., & Gabrieli, C. B. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.07.022 · Cited by 114
Vision performance with a contact lens designed to slow myopia progression
Kollbaum, P. S., Jansen, M. E., Tan, J., Meyer, D. M., & Rickert, M. E. (2013) · Optometry and Vision Science · doi:10.1097/opx.0b013e3182812205 · Cited by 109
Jaffe, G. J., Eliott, D., Wells, J. A., Prenner, J. L., Papp, A., & Patel, S. C. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.09.004 · Cited by 97
Gharbiya, M., Giustolisi, R., Allievi, F., Fantozzi, N., Mazzeo, L., Scavella, V., & Gabrieli, C. B. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.10.010 · Cited by 97
Choroidal Neovascularization in Pathologic Myopia: Recent Developments in Diagnosis and Treatment
Soubrane, G. (2008) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2007.12.004 · Cited by 95
Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia with Verteporfin
Brown, G. C., & Landy, J. (2001) · Evidence-Based Eye Care · doi:10.1097/00132578-200110000-00010 · Cited by 94
Prevention of collagen crosslinking increases form-deprivation myopia in tree shrew
McBrien, N. A., & Norton, T. T. (1994) · Experimental Eye Research · doi:10.1006/exer.1994.1133 · Cited by 92
Chan, W., Lai, T. Y. Y., Chan, K. M., Li, H., LIU, D. T. L., Lam, D. S. C., & Pang, C. (2008) · Retina · doi:10.1097/iae.0b013e31818358b2 · Cited by 89
Fundus Characteristics of High Myopia in Children
Kobayashi, K., Ohno‐Matsui, K., Kojima, A., Shimada, N., Yasuzumi, K., Yoshida, T., Futagami, S., Tokoro, T., & Mochizuki, M. (2005) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-004-0204-6 · Cited by 87
SHORT-TERM EFFICACY AND SAFETY OF INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
da Silva, R. M., Ruiz‐Moreno, J. M., Nascimento, J., Carneiro, Â. M., Rosa, P. C., BARBOSA, A., Carvalheira, F., de Abreu, J. R. F., & Cunha-Vaz, J. G. (2008) · Retina · doi:10.1097/iae.0b013e31817eda41 · Cited by 80
Self-citationHayashi, K., Ohno‐Matsui, K., Teramukai, S., Shimada, N., Moriyama, M., Hayashi, W., Yoshida, T., Tokoro, T., & Mochizuki, M. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.03.026 · Cited by 78
Phillips, J. R., & McBrien, N. A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0732 · Cited by 74
Ruiz‐Moreno, J. M., Arias, L., Montero, J. A., Carneiro, Â. M., & da Silva, R. M. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302973 · Cited by 72
Self-citationTrier, K., Olsen, E. B., Kobayashi, T., & Ribel-Madsen, S. M. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.12.1370 · Cited by 71
NON–FULL-THICKNESS MACULAR HOLES REASSESSED WITH SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY
Michalewska, Z., Michalewski, J., Odrobina, D., & Nawrocki, J. (2011) · Retina · doi:10.1097/iae.0b013e318227a9ef · Cited by 70
Ruiz‐Moreno, J. M., Montero, J. A., Gómez‐Ulla, F., & Ares, S. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.145391 · Cited by 69
Self-citationINTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION COMPLICATING PATHOLOGIC MYOPIA
Lalloum, F., Souied, E. H., Bastuji‐Garin, S., Puche, N., Querques, G., Glacet-Bernard, A., COSCAS, G. J., Soubrane, G., & Leveziel, N. (2010) · Retina · doi:10.1097/iae.0b013e3181bcef24 · Cited by 67
Spaide, R. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8338-0_12 · Cited by 65
Calvo-González, C., Reche-Frutos, J., Donate-López, J., Fernández, C., & Garcia-Sanchez, J. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.09.021 · Cited by 63
Ruiz‐Moreno, J. M., Montero, J. A., Araiz, J., Arias, L., García‐Layana, A., Carneiro, Â. M., Figueroa, M. S., & da Silva, R. M. (2015) · Retina · doi:10.1097/iae.0000000000000632 · Cited by 63
Self-citationLong-Term Follow-Up of Myopic Choroidal Neovascularization Treated with Ranibizumab
Franqueira, N., Cachulo, M. L., Pires, I., Fonseca, P., Marques, I. P., Figueira, J., & da Silva, R. M. (2011) · Ophthalmologica · doi:10.1159/000333213 · Cited by 62
CCDC102B confers risk of low vision and blindness in high myopia
Hosoda, Y., Yoshikawa, M., Miyake, M., Tabara, Y., Shimada, N., Zhao, W., Oishi, A., Nakanishi, H., Hata, M., Akagi, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03649-3 · Cited by 60
Ergun, E., Heinzl, H., & Stur, M. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.04.055 · Cited by 55
Cases, O., Joseph, A., Obry, A., Santin, M. D., Ben-Yacoub, S., Pâques, M., Amsellem, S., Bribián, A., Simonutti, M., Augustin, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129518 · Cited by 53
Chan, W., Lai, T. Y. Y., Wong, A. L., Liu, D. T. L., & Lam, D. S. C. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.103606 · Cited by 50
Ruiz‐Moreno, J. M., Montero, J. A., Arias, L., Araiz, J., Gómez‐Ulla, F., da Silva, R. M., & Pinero, D. P. (2010) · Retina · doi:10.1097/iae.0b013e3181e22659 · Cited by 50
Self-citationRuiz‐Moreno, J. M., Amat, P., Montero, J. A., et al. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.132795 · Cited by 49
Self-citationPece, A., Isola, V., Vadalà, M., & Matranga, D. (2006) · Retina · doi:10.1097/01.iae.0000244256.60524.c0 · Cited by 47
EXTREME CHOROIDAL THINNING IN HIGH MYOPIA
Pang, C. E., Sarraf, D., & Freund, K. B. (2014) · Retina · doi:10.1097/iae.0000000000000368 · Cited by 39
3‐D Choroidal Thickness Maps from EDI‐OCT in Highly Myopic Eyes
Ohsugi, H., Ikuno, Y., Oshima, K., & Tabuchi, H. (2013) · Optometry and Vision Science · doi:10.1097/opx.0b013e3182924017 · Cited by 38
Marticorena, J., Gómez‐Ulla, F., Fernandez, M. B., Pazos, B., Rodríguez‐Cid, M. J., & Sánchez‐Salorio, M. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.03.003 · Cited by 37
Bray, N., Brand, A., Taylor, J. J., Hoare, Z., Dickinson, C., & Edwards, R. T. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13255 · Cited by 34
Long-term variable outcome of myopic choroidal neovascularization treated with ranibizumab
Cohen, S. Y., Nghiem‐Buffet, S., Grenet, T., Dubois, L., Ayrault, S., Fajnkuchen, F., Delahaye-Mazza, C., Quentel, G., & Tadayoni, R. (2014) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-014-0363-z · Cited by 28
Choroidal thickness does not predict visual acuity in young high myopes
Gupta, P., Cheung, C. Y.-L., Saw, S., Koh, V., Tan, M. M. H., Yang, A., Zhao, P., Cheung, C. M. G., Wong, T. Y., & Cheng, C. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13084 · Cited by 28
Yoon, J. U., Kim, Y. M., Lee, S. J., Byun, Y., & Koh, H. J. (2011) · Retina · doi:10.1097/iae.0b013e318227aa09 · Cited by 25
Cheng, J.-W., Cheng, S., Cai, J.-P., Li, Y., & Wei, R.-L. (2012) · Ophthalmic Research · doi:10.1159/000327144 · Cited by 24
Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study
Bruè, C., Pazzaglia, A., Mariotti, C., Reibaldi, M., & Giovannini, A. (2015) · Eye · doi:10.1038/eye.2015.199 · Cited by 23
The Prevalence of High Myopia in 19 Year-Old Men in Busan, Ulsan and Gyeongsangnam-Do
Lee, S. J., Urm, S. H., Yu, B. C., Sohn, H. S., Hong, Y., Noh, M. S., & Lee, Y. H. (2011) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2011.44.1.56 · Cited by 22
PHOTODYNAMIC THERAPY IN HIGHLY MYOPIC EYES WITH CHOROIDAL NEOVASCULARIZATION
Coutinho, A. M., da Silva, R. M., Nunes, S. G., Cachulo, M. L., Figueira, J., & Murta, J. (2011) · Retina · doi:10.1097/iae.0b013e3181ff9546 · Cited by 21
Intravitreal aflibercept for myopic choroidal neovascularization
Pece, A., & Milani, P. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3396-9 · Cited by 19
Parodi, M. B., Iacono, P., & Bandello, F. M. (2017) · Retina · doi:10.1097/iae.0000000000001524 · Cited by 17
Parodi, M. B., Iacono, P., Sacconi, R., Iuliano, L., & Bandello, F. M. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.04.030 · Cited by 14
Intravitreal aflibercept for myopic choroidal neovascularization
Pece, A. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3285-2 · Cited by 13
Korol, A. R., Zadorozhnyy, O., Naumenko, V., Kustryn, T., & Pasyechnikova, N. (2016) · Clinical ophthalmology · doi:10.2147/opth.s117791 · Cited by 13
Lorenzo, D., Arias, L., Alcubierre, R., Goyta, O. P., Mitjana, J. M. C., Rubio, M., Català, J., García-Bru, P., & Arruga, J. (2011) · Ophthalmologica · doi:10.1159/000328980 · Cited by 11
Self-citationAbnormal fundus autofluorescence patterns in myopic choroidal neovascularisation
Sawa, M., Gomi, F., Tsujikawa, M., Ikuno, Y., Sakaguchi, H., Sayanagi, K., & Tano, Y. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.138198 · Cited by 10
Cited by
Brennan, N. A., Toubouti, Y. M., Cheng, X., & Bullimore, M. A. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100923 · Cited by 355
Laíns, I., Wang, J. C., Cui, Y., Katz, R., Vingopoulos, F., Staurenghi, G., Vavvas, D. G., Miller, J. W., & Miller, J. B. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100951 · Cited by 324
Metadata
- Authors
- Ruiz-Medrano, J., Montero, J. A., Flores-Moreno, I., Arias, L., García-Layana, A., & Ruiz-Moreno, J. M.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 69
- Pages
- 80-115
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2899439961
- Cited by
- 446
- References
- 98
- FWCI
- 23.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.